Steven L. Barriere
Chief Tech/Sci/R&D Officer bij Theravance Biopharma US, Inc.
Profiel
Steven L.
Barriere is currently a Clinical Professor at The University of California, San Francisco and a Vice President-Clinical & Medical Affairs at Theravance Biopharma US, Inc. He previously worked as a Vice President-Clinical & Medical Affairs at Innoviva, Inc. He holds a doctorate degree from The University of California, San Francisco.
Actieve functies van Steven L. Barriere
Bedrijven | Functie | Begin |
---|---|---|
The University of California, San Francisco | Corporate Officer/Principal | 25-03-2009 |
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Chief Tech/Sci/R&D Officer | - |
Eerdere bekende functies van Steven L. Barriere
Bedrijven | Functie | Einde |
---|---|---|
INNOVIVA, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Steven L. Barriere
The University of California, San Francisco | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
INNOVIVA, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Theravance Biopharma US, Inc.
Theravance Biopharma US, Inc. Miscellaneous Commercial ServicesCommercial Services Theravance Biopharma US, Inc. operates as a biopharmaceutical company. The firm serves in the areas of inflammation and immunology, drug development programs, including the combination of fluticasone furoate, umeclidinium, and vilanterol. The company is headquartered in South San Francisco, CA. | Commercial Services |